LOAN FULLY REPAID – JUNE 2017
The Company provides processing and cryogenic storage of cord blood and cord tissue specimens for newborn babies, preserving their cord blood stem cells for future use. The Company is over 20 years old and currently stores more than 100,000 specimens.
- Industry Leader: The Company’s cord blood storage holds more cord blood patents than any other private cord blood bank. The Company’s collection, processing and cryopreservation methods safeguard stem cells 30x longer than other private cord blood banks.
- Recurring Revenue: The majority of the Company’s profit is derived from an annual storage fees. In 2015, the Company collected the majority of its revenue from subscribers’ annual storage fees.
- Low Marginal Costs: After the initial intake and processing costs, there are very little incremental ongoing storage costs.